Delivery of Continuous Albuterol During Pediatric Emergency Medical Services Transport.

Cohort studyRespiratory care· Jul 2026

Delivery of Continuous Albuterol During Pediatric Emergency Medical Services Transport.

L Denise Willis, Michael Davis, Paul Britton … Ariel Berlinski

Read paper

Prehospital & RetrievalCohort studyTreatmentQ2IF 1.4

Switching to vibrating mesh nebulizer not linked to change in hospital stay

Delivery of Continuous Albuterol During Pediatric Emergency Medical Services Transport.

L Denise Willis … Ariel Berlinski

Respiratory care · Jul 2026 · Q2 in Critical Care

Background

Severe asthma exacerbation is treated with continuous albuterol.

Purpose

The aim of this study was to evaluate the effect of the practice change on patient outcomes.

Methods

A retrospective review of children with asthma treated with continuous albuterol during inter-facility transport from June 1, 2018, to June 30, 2023.

Results

-0.72

days

hospital stay was similar with vibrating mesh, no meaningful difference

More results

Median age was 6 (3-9) years.

Fifty-two (53%) and 46 (47%) children received continuous albuterol during transport with an LVN or VMN, respectively.

High-flow nasal cannula was used more often during transport when the VMN was used ( P < .001).

More results

Thirty-seven (80%) of children who utilized an LVN during transport were changed to a VMN upon admission.

“

Conclusion

Change in practice from an LVN to a VMN for administration of continuous albuterol during inter-facility transport was not associated with a change in stay or duration of continuous albuterol therapy.

Delivery of Continuous Albuterol During Pediatric Emergency Medical Services Transport.

Delivery of Continuous Albuterol During Pediatric Emergency Medical Services Transport.

Related papers